Mr. Fiocruz and Mr. BioMérieux will open the Diagnostic Research and Innovation Center in Jacarepagua (RJ) this Monday (10th).
The French company plans to completely transfer the space to the foundation and begin operations there in March 2026.
The center will house research and development projects for SUS input and diagnostic kits. Fiocruz said the initiative includes capacity expansion, technology updates, process automation and new technology transfer projects.
The agency also says the space will reduce production time and increase national autonomy in diagnosis.
Fiocruz President Mario Moreira said the agreement strengthens the historic partnership between Brazil and France. The center is a “strategic step to expand national capacity for production and innovation in diagnostics” and has a direct impact on the health emergencies we face. The aim, he said, is to provide tools that are “accurate, timely and sustainable” as technology advances.
and Diego Alejandro, Karina Matias, Victoria Cocoro
Link exists: Did you like this text? Subscribers can access it for free up to 7 times a day from any link. Click on the blue F below.
Your subscription may be worth even more
Are you already aware of the benefits of becoming a Folha subscriber? In addition to access to reports and columns, we also have exclusive newsletters (see here). You can also download our free app from the Apple Store or Google Play to receive alerts on the day’s top stories. Your subscription helps us provide independent, quality journalism. thank you!
Your subscription has great value
Over 180 reports and analyzes published daily. A team of over 200 columnists and bloggers. Professional journalism that monitors public institutions, tells informative and inspiring news, counters intolerance on social media and draws a clear line between truth and lies. How much does it cost to produce this content?
Subscribe for R$ 1.90 for the first month
About The Author
